Hypertension with Anxiety
Conditions
Interventions
control group:Basic treatment: On the basis of health education on diet, exercise, and lifestyle, patients are given conventional Western medicine treatment of hypertension. On this basis, The effecti
test group:Basic treatment: On the basis of health education on diet, exercise, and lifestyle, patients are given conventional Western medicine treatment of hypertension. On this basis, the Chinese m
Sponsors
Shuguang hospital
Eligibility
Sex/Gender
All
Age
35 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Patients with essential hypertension who have taken antihypertensive drugs or meet the diagnostic criteria for hypertension in the "Chinese Guidelines for the Prevention and Treatment of Hypertension 2010": without antihypertensive drugs, measure blood pressure three times on different days, and systolic blood pressure >=140mmHg and /Or patients with diastolic blood pressure >=90 mmHg; 2. Patient mental health questionnaires conducted by professional psychologists, including GAD7 Anxiety Disorder Screening Scale and Hamilton Anxiety Scale (HAMA), GAD7 >=5 points and =7 points and Patients with <=21 points; 3. Meet the syndrome differentiation standard of "Yin deficiency and Yang hyperactivity" in TCM; 4. A history of oral anti-anxiety drugs but intolerance occurred; 5. Aged between 35 and 85 years old; 6. Stop taking other similar Chinese medicines and proprietary Chinese medicines during clinical observation; 7. Those who can cooperate in filling out questionnaires and surveys, and those who give informed consent.
Exclusion criteria
Exclusion criteria: 1. Acute myocardial infarction, unstable angina pectoris; 2. Patients with other heart diseases or severe cardiac insufficiency (NYHA cardiac function classification> Grade III); 3. Patients with poor control after standardized treatment of hypertension (blood pressure>170/105mmHg); 4. Severe arrhythmias, persistent rapid atrial fibrillation (average ventricular rate in a calm state> 100 beats/minute), atrial flutter (average ventricular rate in a calm state> 100 beats/minute), frequent ventricular early (24 hours ventricular Premature beats> 7200) or ventricular tachycardia; 5. Patients with severe primary diseases such as brain, liver, kidney, hematopoietic system; 6. Diabetic patients with unstable blood sugar control and diabetic ketoacidosis; 7. Patients with serious mental illnesses, such as hallucinations, delusions, panic and suicidal behaviors; Generalized Anxiety Disorder Scale (GAD-7 Scale)>14 points and Hamilton Anxiety Scale (HAMA)>21 points; 8. Women during pregnancy or lactation, as well as men and women of childbearing age who have recent birth plans; 9. Allergic patients who are allergic to the test drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| GAD-7;Hamilton Anxiety Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood pressure;TCM single symptom score;SRSS;TCM syndrome curative effect score; | — |
Countries
China
Contacts
Public ContactTao Liyu
Shuguang Hospital Affiliated to Shanghai University of Chinese Medicine
Outcome results
None listed